Protara Therapeutics is trading at $3.50 (-10.26%), with no credible company-specific catalyst identified.
- No credible August 21, 2026 company-specific announcement or overnight catalyst was identified.
- The latest update, on August 11, 2026, covered second-quarter results and a business update, making it stale for this move.
- Broader markets are higher; the catalyst remains unclear and should be rechecked after the market opens.